Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Basel Medical (BMGL) EPS (Weighted Average and Diluted): 2023-2024

Historic EPS (Weighted Average and Diluted) for Basel Medical (BMGL) over the last 2 years, with Q4 2024 value amounting to -$0.01.

  • Basel Medical's EPS (Weighted Average and Diluted) fell 10907.94% to -$0.01 in Q4 2024 from the same period last year, while for Jun 2025 it was -$0.03, marking a year-over-year change of. This contributed to the annual value of -$0.51 for FY2025, which is 62466.88% down from last year.
  • According to the latest figures from Q4 2024, Basel Medical's EPS (Weighted Average and Diluted) is -$0.01, which was down 10907.94% from $0.16 recorded in Q4 2023.
  • In the past 5 years, Basel Medical's EPS (Weighted Average and Diluted) ranged from a high of $0.16 in Q4 2023 and a low of -$0.01 during Q4 2024